The Relationship Between Liver Fibrosis and Golgi Protein 73 in Patients with Chronic Hepatitis B

Aim: This study aimed to determine the relationship between the degree of liver fibrosis and serum Golgi protein 73 (sGP73) concentration in patients with chronic hepatitis B (HBV) infection. Materials and Methods: A total of 124 (78 HBV-positive, 40 healthy) individuals were included in the study....

Full description

Bibliographic Details
Published in:	Namık Kemal Tıp Dergisi
Main Authors:	Cemil İNCİ, Hatice TERZİ, Halef Okan DOĞAN, Şeyma Nur YILDIZ, Abdulkerim YILMAZ
Format:	Article
Language:	English
Published:	Tekirdağ Namık Kemal University 2025-06-01
Subjects:	gp73 hepatitis b virus fibrosis
Online Access:	https://namikkemalmedj.com/articles/the-relationship-between-liver-fibrosis-and-golgi-protein-73-in-patients-with-chronic-hepatitis-b/doi/nkmj.galenos.2025.92499

Similar Items

Expression and mechanism of gp73 in liver tissue of mouse liver fibrosis
by: MA Ling-yu, ZHEN Yi-ning, LUO Yun-ping, DUAN Zhao-jun
Published: (2020-06-01)

Rapid detection of Golgi protein 73 by MAGLUMI chemiluminescent immunoassay and the clinical value to liver fibrosis/cirrhosis patients with chronic liver disease
by: Lu Wang, et al.
Published: (2025-10-01)

Possible roles of Golgi protein-73 in liver diseases
by: Meng-Yuan Liu, et al.
Published: (2022-09-01)

Golgi protein 73: charting new territories in diagnosing significant fibrosis in MASLD: a prospective cross-sectional study
by: Shan Hong, et al.
Published: (2025-01-01)

Diagnostic role of serum Golgi protein 73 as a biomarker for the assessment of significant hepatic fibrosis in patients with chronic hepatitis B infection
by: Ahmed Mohamed ElGhandour, et al.
Published: (2025-06-01)

Serum Golgi protein 73 (GP73) is a diagnostic and prognostic marker of hepatocellular carcinoma
by: Qian Wang, et al.
Published: (2025-04-01)

Whether the Golgi protein 73 could be a diagnostic serological marker in hepatocellular carcinoma: a meta analysis
by: Xu Zhang, et al.
Published: (2023-03-01)

Serum GP73 predicts posthepatectomy outcomes in patients with hepatocellular carcinoma
by: Meng-yun Ke, et al.
Published: (2019-05-01)

Combining AFP, PIVKA-II, and GP73 has diagnostic utility for hepatitis B-associated hepatocellular carcinoma and is consistent with liver pathology results
by: Hu Rui, et al.
Published: (2025-04-01)

Development and analytical performance of a new research use only (RUO) GP73 automated immunoassay
by: Shaohua Ning, et al.
Published: (2025-03-01)

Superior Diagnostic Efficacy of N‐Terminal Propeptide of Type III Collagen and Golgi Protein 73 for Detection of Fibrosis in Chronic Hepatitis B Patients
by: Qianqian Chen, et al.
Published: (2025-06-01)

PTEN deficiency potentiates HBV-associated liver cancer development through augmented GP73/GOLM1
by: Fuqiang Huang, et al.
Published: (2024-03-01)

Rapamycin inhibits colorectal cancer progression through down-regulating mTOR-GP73 pathway
by: ZHANG Meng-di, WANG Ya-nan, LI Jie, PU Yang
Published: (2020-07-01)

Diagnostic and Prognostic Value of Serum Golgi Protein 73 in Patients With Hepatitis B Virus‐Associated Acute‐on‐Chronic Liver Failure
by: Zheng‐ju Xu, et al.
Published: (2025-02-01)

The use of biomarkers GP-73 and AFP in the early diagnosis of hepatocarcinoma associated with liver cirrhosis of HCV etiology
by: A. K. Bayjanov, et al.
Published: (2025-06-01)

Diagnostic Accuracy of Golgi Protein 73 (GP73) for Liver Fibrosis Staging in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Scoping Review and Cohort Study
by: Valentina Pecoraro, et al.
Published: (2025-02-01)

A meta-analysis of the prognostic impact of tissue golgi protein 73 (tGP73) in hepatocellular carcinoma
by: Wei-Ming Yu, et al.
Published: (2023-11-01)

Golgi protein 73 and IL-6 as strong predictors of short-term prognosis in patients with HBV-ACLF
by: Xiaoman Zhang, et al.
Published: (2025-07-01)

Golgi protein 73: the driver of inflammation in the immune and tumor microenvironment
by: Pingping Feng, et al.
Published: (2025-01-01)

Hepatitis B virus promotes hepatocellular carcinoma development by activating GP73 to repress the innate immune response
by: Long Liu, et al.
Published: (2022-10-01)

Golgi Protein 73 versus Alpha-Fetoprotein as a New Biomarker in Early Diagnosis of Hepatocellular Carcinoma
by: Ali OM, et al.
Published: (2020-05-01)

Ultrasonic Parameters as Biomarkers for Tumor Staging and Aggressiveness in Breast Cancer: Correlation with GP73 and miR-27a
by: Tao ZY, et al.
Published: (2025-06-01)

Targeting the CD39/CD73 pathway: New insights into cardiac fibrosis and inflammation in female cardiac surgery patients
by: Eitezaz Mahmood, et al.
Published: (2025-06-01)

Deoxycholic Acid Upregulates Serum Golgi Protein 73 through Activating NF-κB Pathway and Destroying Golgi Structure in Liver Disease
by: Danli Yang, et al.
Published: (2021-02-01)

Apolipoprotein E negatively regulates Golgi membrane protein 73 to inhibit the proliferation of mouse liver cancer cell lines
by: HOU Mengjie, ZHAO Na, HUANG Fuqiang, WANG Yanan, LIU Fangming
Published: (2023-05-01)

Isoform-specific disruption of the TP73 gene reveals a critical role for TAp73γ in tumorigenesis via leptin
by: Xiangmudong Kong, et al.
Published: (2023-08-01)

The Relationship between Golgi Protein 73, Alpha-Fetoprotein, Liver Function Indicators, and Traditional Chinese Medicine Syndrome Types of Primary Liver Cancer
by: Baoping Lu, et al.
Published: (2023-12-01)

GOLM1 depletion modifies cellular sphingolipid metabolism and adversely affects cell growth
by: Meghana Nagaraj, et al.
Published: (2022-09-01)

Effect of Allostatic Load on hepatic steatosis and fatty liver-associated liver fibrosis
by: Lei Zhang, et al.
Published: (2025-07-01)

CD73 mediates the therapeutic effects of endometrial regenerative cells in concanavalin A-induced hepatitis by regulating CD4+ T cells
by: Hong Qin, et al.
Published: (2023-09-01)

The Value of Fibrosis Index in Discrimination of Chronic Hepatitis and Cirrhosis
by: Gökhan Söker, et al.
Published: (2017-09-01)

The role of hepatic microenvironment in hepatic fibrosis development
by: Ying Meng, et al.
Published: (2022-12-01)

Mouse cortical organoids reveal key functions of p73 isoforms: TAp73 governs the establishment of the archetypical ventricular-like zones while DNp73 is central in the regulation of neural cell fate
by: Hugo Alonso-Olivares, et al.
Published: (2024-09-01)

Hepatic Fibrosis and Steatosis in Metabolic Syndrome
by: Venu Gopala Reddy Gangireddy, et al.
Published: (2022-03-01)

CD73, a significant protein in liver diseases
by: Huilian Shi, et al.
Published: (2023-04-01)

Morphological and ultrasound features of liver fibrosis in children with autoimmune hepatitis
by: V. S. Berezenko, et al.
Published: (2018-12-01)

Staging Fibrosis in Chronic Viral Hepatitis
by: Ana Carolina Cardoso, et al.
Published: (2022-03-01)

Angiogenesis and experimental hepatic fibrosis
by: Queli Teixeira Lemos, et al.
Published: (2010-08-01)

Apoptosis and progression of hepatic fibrosis in hepatitis C patients
by: Maria Isabel Schinoni, et al.

Simple Tests to Predict Hepatic Fibrosis in Nonalcoholic Chronic Liver Diseases
Published: (2007-12-01)